Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort
Cancer · 2024
DOI: 10.1002/cncr.35386 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer, 2024. Verfasst von Shane A Tinsley und 18 weiteren Autor:innen. Beteiligte Einrichtung: VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Black or African American, Prostatic Neoplasms, SEER Program, White. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Menon Foundation, Vattikuti Foundation.
Abstract (Originalsprache)
Background
Other‐cause mortality (OCM) can serve as a surrogate for access‐to‐care. The authors sought to compare prostate cancer–specific mortality (PCSM) in Black versus White men matched based on their calculated OCM risk.
Methods
The Surveillance, Epidemiology, and End Results (SEER) database was queried for Black and White men diagnosed with prostate cancer between 2004 to 2009, to collect long‐term follow‐up. A Cox regression was used to calculate the OCM risk using all available covariates. This calculated OCM risk was used to construct a 1:1 propensity score matched (PSM) cohort. Then, a competing‐risks multivariable tested the impact of race on PCSM.
Results
A total of 94,363 patients were identified, with 19,398 Black men and 74,965 White men. The median (IQR) follow‐up was 11.3 years (9.8–12.8). In the unmatched‐cohort at 10‐years, PCSM and OCM were 5.5% versus 3.5% and 13.8% versus 8.4% in non‐Hispanic Black (NHB) versus non‐Hispanic White (NHW) patients (all p < .0001). The standardized mean difference was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health, Detroit, Michigan, USA.
- Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
- Public Health Sciences, Henry Ford Health, Detroit, Michigan, USA.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
- Wayne State University School of Medicine, Detroit, Michigan, USA.
ORCID-Profile: Akshay Sood, Firas Abdollah
Förderung
- Menon Foundation
- Vattikuti Foundation
Zitieren
APA
Tinsley, S. A., Finati, M., Stephens, A., Chiarelli, G., Cirulli, G. O., Williams, E., Morrison, C., Richard, C., Hares, K., Sood, A., Buffi, N., Lughezzani, G., Bettocchi, C., Salonia, A., Briganti, A., Montorsi, F., Carrieri, G., Rogers, C., & Abdollah, F. (2024). Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort. Cancer. https://doi.org/10.1002/cncr.35386
Vancouver
Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, et al. Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort. Cancer. 2024. doi:10.1002/cncr.35386
BibTeX
@article{Tinsley2024,
author = {Tinsley, Shane A and Finati, Marco and Stephens, Alex and Chiarelli, Giuseppe and Cirulli, Giuseppe Ottone and Williams, Eric and Morrison, Chase and Richard, Caleb and Hares, Keinnan and Sood, Akshay and Buffi, Nicolòs and Lughezzani, Giovanni and Bettocchi, Carlo and Salonia, Andrea and Briganti, Alberto and Montorsi, Francesco and Carrieri, Giuseppe and Rogers, Craig and Abdollah, Firas},
title = {Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35386}
}
EUVIMED